Jeffrey W. Sherman, M.D., FACP

2019

In 2019, Jeffrey W. Sherman, M.D., FACP earned a total compensation of $3.6M as Executive Vice President, Chief Medical Officer at Horizon Pharma, a 3% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$687,473
Salary$559,630
Stock Awards$2,226,172
Other$95,222
Total$3,568,496

FACP received $2.2M in stock awards, accounting for 62% of the total pay in 2019.

FACP also received $687.5K in non-equity incentive plan, $559.6K in salary and $95.2K in other compensation.

Rankings

In 2019, Jeffrey W. Sherman, M.D., FACP's compensation ranked 3,398th out of 13,971 executives tracked by ExecPay. In other words, FACP earned more than 75.7% of executives.

ClassificationRankingPercentile
All
3,398
out of 13,971
76th
Division
Manufacturing
1,235
out of 5,695
78th
Major group
Chemicals And Allied Products
421
out of 2,194
81st
Industry group
Drugs
349
out of 1,880
81st
Industry
Pharmaceutical Preparations
262
out of 1,392
81st

Pay ratio

Jeffrey W. Sherman, M.D., FACP's Pay$3,568,496
Median Employee's Pay$250,565
Pay Ratio

to 1

In 2019, the annual total compensation of Jeffrey W. Sherman, M.D., FACP was $3,568,496.

The annual total compensation of the median employee at Horizon Pharma was $250,565.

The ratio of Jeffrey W. Sherman, M.D., FACP's pay to the pay of median employee was therefore to one.

Source: SEC filing on March 17, 2021.

FACP's colleagues

We found eight more compensation records of executives who worked with Jeffrey W. Sherman, M.D., FACP at Horizon Pharma in 2019.

2019

Timothy Walbert

Horizon Pharma

Chief Executive Officer

2019

Barry Moze

Horizon Pharma

Chief Administrative Officer

2019

Paul Hoelscher

Horizon Pharma

Chief Financial Officer

2019

Robert Carey

Horizon Pharma

Former Executive Vice President, Chief Business Officer

2019

Shao-Lee Lin

Horizon Pharma

Chief Scientific Officer

2019

Vikram Karnani

Horizon Pharma

Executive Vice President, Chief Commercial Officer

2019

Brian Beeler

Horizon Pharma

General Counsel

2019

Andy Pasternak

Horizon Pharma

Executive Vice President, Chief Strategy Officer

News

You may also like